Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference

LONDON and NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,...
April 25, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019

LONDON and NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced a pre-clinical poster on...
March 26, 2019 16:05 ET | Source: MeiraGTx

MeiraGTx Reports Full Year 2018 Financial Results

LONDON and NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results...
March 06, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx to Present at the Barclays Global Healthcare Conference

LONDON and NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
February 27, 2019 08:15 ET | Source: MeiraGTx

MeiraGTx Announces $80 Million Private Placement of Ordinary Shares

LONDON and NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell...
February 21, 2019 16:30 ET | Source: MeiraGTx

MeiraGTx Appoints Martin Indyk, Ph.D. to Board of Directors

LONDON and NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of...
February 05, 2019 08:30 ET | Source: MeiraGTx

MeiraGTx to Present at the BIO CEO & Investor Conference

LONDON and NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
January 31, 2019 06:30 ET | Source: MeiraGTx

MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases

-- Conference call and webcast today, January 31, 2019 at 8:30 a.m. EST -- MeiraGTx to receive $100 million cash upfront payment upon closing -- MeiraGTx to receive 20% net sales royalties and...
January 02, 2019 08:30 ET | Source: MeiraGTx

MeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare Conference

LONDON and NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
December 12, 2018 08:30 ET | Source: MeiraGTx

MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson’s Disease

Findings Published in Science Translational Medicine Show AAV-GAD Exerts Clinical Benefits by Inducing the Formation of New Brain Pathways Results Expand on Findings from Completed Phase 2 Clinical...